Preview

Сибирский научный медицинский журнал

Advanced search

Features of bone tissue reconstruction in periand postmenopausal women with type 1 diabetes mellitus

https://doi.org/10.15372/SSMJ20180209

Abstract

Aim of the study - to assess the impact of changes in women’s bodies with diabetes mellitus type 1 on the state of bone mineral density and its metabolic rate, to determine the tendency of changes in serum markers of bone remodeling and bone mineral density in peri- and postmenopausal periods in women with this disease. Material and methods: T-score of bone mineral density (by dual-energy X-ray absorbtiometry) and serum markers of bone remodeling (alkaline phosphatase activity, amino-terminal propeptide of type I collagen and C-terminal telopeptide), were measured in 57 peri- and postmenopausal women with type 1 diabetes and in the control group consisting of 43 women. Results. The obtained results indicate inconsistency of changes in bone remodeling processes in patients with type 1 diabetes with predominant bone formation changes (35.5 %) vs. bone resorbtion (16.6 %, p < 0.001). A positive correlation between the duration of type 1 diabetes and the level of b-C-terminal telopeptide ( r = 0.465, p = 0.001) was established in postmenopausal women. A negative correlation between the change in the T-score of the femoral neck and duration of diabetes ( r = -0.416, p = 0.04) was found in the subgroup of postmenopausal women. A statistically significant correlation between the T-score of the lumbar spine and the level of C-terminal telopeptide ( r = -0.489, p = 0.003) was revealed. Conclusions. Bone mineral density in postmenopausal women with type 1 diabetes demonstrates an earlier and accelerated bone mass loss, especially in the lumbar spine. The bone mass loss in the most of the examined patients is associated with the suppression of bone formation and, to a much lesser extent, with bone resorption, which is significantly accelerated during the late perimenopause and continues at a similar pace in the early years of postmenopause with decrease in the intensity of loss in the subsequent.

About the Author

S. S. Safarova
Azerbaijan Medical University
Russian Federation


References

1. Соловьёва-Савоярова Г.Е., Дрожжина В.А. Эстрогены и некариозные поражения зубов. СПб., 2012. 140 с.

2. Adami S. Bone health in diabetes: considerations for clinical management // Curr. Med. Res. Opin. 2009. 25. (5). 1057-1072.

3. Al-Hariri M. Sweet bones: The pathogenesis of bone alteration in diabetes // J. Diabetes Res. 2016. 2016. ID 6969040.

4. Christgau S., Rosenquist C., Alexandersen P., Bjarnason N.H., Ravn P., Fledelius C., Herling C., Qvist P., Christiansen C. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides // Clin. Chem. 1998. 44. (11). 2290-2300.

5. Farr J.N., Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans // Bone. 2016. 82. 28-34.

6. Gunczler P., Lanes R., Paoli M., Martinis R., Villaroel O., Weisinger J.R. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus // J. Pediatr. Endocrinol. Metab. 2001. 14. (5). 525-528.

7. Hough F.S., Pierroz D.D., Cooper C., Ferrari S.L. Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus // Eur. J. Endocrinol. 2016. 174. (4). R127-R138.

8. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., Smals A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology // J. Endocrinol. Invest. 2000. 23. (5). 295-303.

9. Pramojanee S.N., Phimphilai M., Chattipakorn N., Chattipakorn S.C. Possible roles of insulin signaling in osteoblasts // Endocrine Res. 2014. 39. (4). 144-151.

10. Saito M., Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus // Osteoporos. Int. 2010. 21. 195-214.

11. Seibel M.J. Biochemical markers of bone turnover part I: Biochemistry and variability // Clin. Biochem. Rev. 2005. 26. (4). 97-122.

12. Seibel M.J. Biochemical markers of bone turnover part II: Clinical applications in the management of osteoporosis // Clin. Biochem. Rev. 2006. 27. (3). 123-138.

13. Starup-Linde J., Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - a systematic review // Bone. 2016. 82. 69-78.

14. Thrailkill K.M., Liu L., Wahl E.C., Bunn R.C., Perrien D.S., Cockrell G.E., Skinner R.A., Hogue W.R., Carver A.A., Fowlkes J.L., Aronson J., Lumpkin C.K., Jr. Bone formation is impaired in a model of type 1 diabetes // Diabetes. 2005. 54. (10). 2875-2881.

15. Vestergaard P., Rejnmark L., Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes // Calcif. Tissue Int. 2009. 84. (1). 45-55.


Review

For citations:


Safarova S.S. Features of bone tissue reconstruction in periand postmenopausal women with type 1 diabetes mellitus. Сибирский научный медицинский журнал. 2018;38(2):56-61. (In Russ.) https://doi.org/10.15372/SSMJ20180209

Views: 226


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2410-2512 (Print)
ISSN 2410-2520 (Online)